210 related articles for article (PubMed ID: 16253214)
41. How could analyzing the activity of two matrix metalloproteinases unveil the cause of sudden cardiac death.
Sosa I; Grubesic A
Int J Immunopathol Pharmacol; 2016 Dec; 29(4):712-714. PubMed ID: 27271976
[TBL] [Abstract][Full Text] [Related]
42. Matrix metalloproteinases and their function in myocardium.
Kukacka J; Průsa R; Kotaska K; Pelouch V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2005 Dec; 149(2):225-36. PubMed ID: 16601761
[TBL] [Abstract][Full Text] [Related]
43. What has been learned about the cardiovascular effects of matrix metalloproteinases from mouse models?
Janssens S; Lijnen HR
Cardiovasc Res; 2006 Feb; 69(3):585-94. PubMed ID: 16426591
[TBL] [Abstract][Full Text] [Related]
44. Deletion of extracellular matrix metalloproteinase inducer/CD147 induces altered cardiac extracellular matrix remodeling in aging mice.
Huet E; Gabison E; Vallee B; Mougenot N; Linguet G; Riou B; Jarosz C; Menashi S; Besse S
J Physiol Pharmacol; 2015 Jun; 66(3):355-66. PubMed ID: 26084217
[TBL] [Abstract][Full Text] [Related]
45. Alteration of matrix metalloproteinases in selective left ventricular adriamycin-induced cardiomyopathy in the pig.
Goetzenich A; Hatam N; Zernecke A; Weber C; Czarnotta T; Autschbach R; Christiansen S
J Heart Lung Transplant; 2009 Oct; 28(10):1087-93. PubMed ID: 19782292
[TBL] [Abstract][Full Text] [Related]
46. Novel approaches to retard ventricular remodeling in heart failure.
Spinale FG
Eur J Heart Fail; 1999 Mar; 1(1):17-23. PubMed ID: 10937974
[TBL] [Abstract][Full Text] [Related]
47. Matrix metalloproteinases and matrix receptors in progression and reversal of kidney disease: therapeutic perspectives.
Ronco P; Chatziantoniou C
Kidney Int; 2008 Oct; 74(7):873-8. PubMed ID: 18650796
[TBL] [Abstract][Full Text] [Related]
48. Extracellular matrix profiles in the progression to heart failure. European Young Physiologists Symposium Keynote Lecture-Bratislava 2007.
Graham HK; Horn M; Trafford AW
Acta Physiol (Oxf); 2008 Sep; 194(1):3-21. PubMed ID: 18577182
[TBL] [Abstract][Full Text] [Related]
49. The role of matrix metalloproteinases in aging: Tissue remodeling and beyond.
Freitas-Rodríguez S; Folgueras AR; López-Otín C
Biochim Biophys Acta Mol Cell Res; 2017 Nov; 1864(11 Pt A):2015-2025. PubMed ID: 28499917
[TBL] [Abstract][Full Text] [Related]
50. Matrix metalloproteinases/tissue inhibitors of metalloproteinases: relationship between changes in proteolytic determinants of matrix composition and structural, functional, and clinical manifestations of hypertensive heart disease.
Ahmed SH; Clark LL; Pennington WR; Webb CS; Bonnema DD; Leonardi AH; McClure CD; Spinale FG; Zile MR
Circulation; 2006 May; 113(17):2089-96. PubMed ID: 16636176
[TBL] [Abstract][Full Text] [Related]
51. Metalloproteinases: A parade of functions in matrix biology and an outlook for the future.
Apte SS; Parks WC
Matrix Biol; 2015; 44-46():1-6. PubMed ID: 25916966
[TBL] [Abstract][Full Text] [Related]
52. Matrix reloaded: the matrix metalloproteinase paradox.
Panek AN; Bader M
Hypertension; 2006 Apr; 47(4):640-1. PubMed ID: 16505199
[No Abstract] [Full Text] [Related]
53. Localizing matrix metalloproteinase activities in the pericellular environment.
Murphy G; Nagase H
FEBS J; 2011 Jan; 278(1):2-15. PubMed ID: 21087456
[TBL] [Abstract][Full Text] [Related]
54. Metalloproteinases and metalloproteinase inhibitors in age-related diseases.
Gargiulo S; Gamba P; Poli G; Leonarduzzi G
Curr Pharm Des; 2014; 20(18):2993-3018. PubMed ID: 24079771
[TBL] [Abstract][Full Text] [Related]
55. The role of TIMPs in regulation of extracellular matrix proteolysis.
Arpino V; Brock M; Gill SE
Matrix Biol; 2015; 44-46():247-54. PubMed ID: 25805621
[TBL] [Abstract][Full Text] [Related]
56. Biomarkers of apoptosis, inflammation, and cardiac extracellular matrix remodelling in the prognosis of heart failure.
Osmancik P; Louckova A
Kardiol Pol; 2017; 75(4):295-305. PubMed ID: 27747854
[No Abstract] [Full Text] [Related]
57. Roles of MMP/TIMP in regulating matrix swelling and cell migration during chick corneal development.
Huh MI; Lee YM; Seo SK; Kang BS; Chang Y; Lee YS; Fini ME; Kang SS; Jung JC
J Cell Biochem; 2007 Aug; 101(5):1222-37. PubMed ID: 17295208
[TBL] [Abstract][Full Text] [Related]
58. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function.
Lindsey ML; Goshorn DK; Squires CE; Escobar GP; Hendrick JW; Mingoia JT; Sweterlitsch SE; Spinale FG
Cardiovasc Res; 2005 May; 66(2):410-9. PubMed ID: 15820210
[TBL] [Abstract][Full Text] [Related]
59. Integration of concepts: cardiac extracellular matrix remodeling after myocardial infarction.
Cleutjens JP; Creemers EE
J Card Fail; 2002 Dec; 8(6 Suppl):S344-8. PubMed ID: 12555143
[TBL] [Abstract][Full Text] [Related]
60. Myocardial recovery from ischemia-reperfusion is compromised in the absence of tissue inhibitor of metalloproteinase 4.
Takawale A; Fan D; Basu R; Shen M; Parajuli N; Wang W; Wang X; Oudit GY; Kassiri Z
Circ Heart Fail; 2014 Jul; 7(4):652-62. PubMed ID: 24842912
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
